Table 1.
Participant demographics for the control group and all participants with psychosis.
| Control | Psychosis | Group Differences | ||||
|---|---|---|---|---|---|---|
| Total (n) | 44 (33.8%) | 86 (66.2%) | ||||
| Sex | Female (n) | 25 (41.0%) | 36 (59.0%) | χ2(3) = 2.615, p = 0.106 |
||
| Male (n) | 19 (27.5%) | 50 (72.5%) | ||||
| Race | Caucasian, non-Hispanic (n) | 12 (54.5%) | 10 (45.5%) | χ2(3) = 22.494, p < 0.001 |
||
| Black, non-Hispanic (n) | 18 (22.5%) | 62 (77.5%) | ||||
| Asian or other Pacific Islander (n) | 10 (83.3%) | 2 (16.7%) | ||||
| Hispanic (n) | 4 (25.0%) | 12 (75.0%) | ||||
| Antipsychotic Use | Yes (n) | 0 | 77 | |||
| No (n) | 44 | 9 | ||||
| Other medication * | Yes (n) | 4 | 9 | |||
| No (n) | 40 | 77 | ||||
| Smoking | Yes(n) | 7 | 39 | χ2(3) = 11.034, p = 0.001 |
||
| No (n) | 37 | 47 | ||||
| Age (Mean ± SD) | 38.77 ± 12.82 | 40.21 ± 12.98 |
t(128) = −0.600, p = 0.55 |
|||
| BMI (Mean ± SD) | 28.93 ± 8.1 | 30.8 ± 8.15 |
t(128) = 1.241, p = 0.217 |
|||
| Mean | SD | Mean | SD | |||
| Age at onset of illness | ~ | ~ | 21.32 | 7.88 | ||
| Duration of untreated psychosis | ~ | ~ | 2.97 | 5.85 | ||
| Duration of illness | ~ | ~ | 19.33 | 14.35 | ||
* Other medications indicate that the participant is concurrently taking a medication other than an antipsychotic, including hypertension, diabetes, etc. SD = Standard deviation. Age, age at onset of illness, duration of untreated psychosis and duration of illness are all reported in years.